Ridgeback Capital
Finance · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
348 W 14th St, New York City, New York, ...Phone Number
(212) 624-2543Website
www.ridgebackcap.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
2
1
About Ridgeback Capital
Ridgeback Capital Management is an actively managed private investment company that specializes in securities trading and long-term private investments, primarily focusing on life science companies. Founded in 2006 by Wayne Holman, the firm aims to support innovators in the healthcare sector by investing in private and public companies that are developing life-saving technologies. Ridgeback Capital emphasizes the importance of patient capital for the successful development of new healthcare innovations. The company's commitment to transformative medicines positions it as a key player in addressing unmet healthcare needs.Explore more
Ridgeback Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ridgeback Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ridgeback Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Ridgeback Capital
Click to see if Ridgeback Capital had a recent Job posting/layoffs
Check if Ridgeback Capital has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Ridgeback Capital is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Ridgeback Capital has new funding data
Product Launch: Get notified when Ridgeback Capital launches new products
Earning: See what the market has to say on Ridgeback Capital recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Ridgeback Capital as Masked Content
Find 2 more new buyers
Compare Similar Companies to Ridgeback Capital
Compare insights from companies similar to Ridgeback Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ridgeback Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Ridgeback Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Ridgeback Capital.
Ridgeback Capital Tech Stack
A closer look at the technologies used by Ridgeback Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Ridgeback Capital News & Media
LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital
SAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve near vision in people with presbyopia, today announced that it has entered into a stock purchase agreement with Ridgeback Capital Investments L.P. (“Ridgeback Capital”) for a $30 million private investment in public equity (“PIPE”) common stock financing.Merck and Ridgeback Announce New Data For Investigational LAGEVRIO™ (molnupiravir) From Phase 3 MOVe-OUT Study
RAHWAY, N.J. & MIAMI--(BUSINESS WIRE)---- $MRK #MRK--Merck and Ridgeback Announce New Data For Investigational LAGEVRIO™ (molnupiravir) From Phase 3 MOVe-OUT StudyMerck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO™ (molnupiravir) Was Associated With More Rapid Elimination of Infectious SARS-CoV-2 Than Placebo
KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)---- $MRK #MRK--Merck & Ridgeback to Present Data Demonstrating LAGEVRIO (molnupiravir) Associated With More Rapid Elimination of Infectious SARS-CoV-2 Than PlaceboMerck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States
KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)---- $MRK #MRK--Merck and Ridgeback Announce 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Supplied to the U.S. Government
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ridgeback Capital
Sign Up For FreeTo access detailed company insights
Ridgeback Capital Management is an actively managed private investment company that specializes in securities trading and long-term private investments, primarily focusing on life science companies. Founded in 2006 by Wayne Holman, the firm aims to support innovators in the healthcare sector by investing in private and public companies that are dev... Read More
